Dr. Moukharskaya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
105 Topsham Fair Mall Rd
Unit 1
Topsham, ME 04086Phone+1 207-303-3300Fax+1 207-250-2137
Education & Training
University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
East Tennessee State University/Quillen College of MedicineResidency, Internal Medicine, 2008 - 2011
Minsk Medical InstituteClass of 1998
Certifications & Licensure
FL State Medical License 2023 - Present
ME State Medical License 2013 - 2027
NH State Medical License 2022 - 2026
WA State Medical License 2018 - 2023
VT State Medical License 2011 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 18 citationsRandomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastimJulia Moukharskaya, D M Abrams, Takamaru Ashikaga, Farrah B. Khan, Joanna Schwartz
Supportive Care in Cancer. 2016-02-19 - 11 citationsSynergistic growth inhibition of PC3 prostate cancer cells with low-dose combinations of simvastatin and alendronate.Mailien Rogers, Sumit Kalra, Julia Moukharskaya, Kanishka Chakraborty, Maximilian Niyazi
Anticancer Research. 2015-04-01 - 32 citationsTopoisomerase 1 inhibitors and cancer therapy.Julia Moukharskaya, Claire F. Verschraegen
Hematology/oncology Clinics of North America. 2012-06-01
Press Mentions
10 Recent Oncology PartnershipsAugust 23rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
